Development of a Machine Learning Model for Aspyre Lung Blood: A New Assay for Rapid Detection of Actionable Variants From Plasma in Patients With Non-Small Cell Lung Cancer. - Palmer RN; Abujudeh S; Stolarek-Januszkiewicz M; Silva AL; Mordaka JM; von Bargen K; Collazos A; Andreazza S; Potts ND; Ho CH; Turner I; Jose J; et al. (JCO clinical cancer informatics, 2025)